Michelle Rosenzwajg is at the head of the immunomonitoring team of the Clinical Investigation Center in Biotherapy. She is involved in translational research towards a better understanding of immunopathologies and the development from bench to bedside of immunotherapies in the field of cancer and autoimmune diseases. During the last decade, the team has pioneered the clinical use of low-dose IL-2 as a safe Treg inducer in autoimmune diseases Through an expertise in flow cytometry and cellular immunology, she developed methods for deep immunophenotyping to characterized the immune responses in patients included in low-dose IL-2 trials as well as to study the pathophysiology of auto-inflammatory-autoimmune disease continuum which represents a large part of the potential indications of IL2.
There are two parts to the Festival of Biologics: the five world-class international conferences covering Antibodies, Immunotherapy, BioSimilars, Clinical Trials, and High Potency APIs; and an exhibition featuring the most exciting technology and solutions for pharma and biotech. There is a registration fee to attend the conferences. To visit the exhibition is free.
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October
To sponsor or exhibit contact:
Derek Cavanagh
+44 (0)207 092 1297
derek.cavanagh@terrapinn.com
To speak:
Joan Shutt
+44 (0)207 092 1134
joan.shutt@terrapinn.com